吴瑞,李海军,刘胜武,曹钰琨
WU Rui,LI Haijun,LIU Shengwu,CAO Yukun

• 1:延安大学附属医院心脑血管专科病区
• 2:中国人民解放军空军总医院心脏外科

摘要(Abstract)：

目的:探讨重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗对急性脑梗死的疗效。方法:将28例急性脑梗死患者随机分为对照组和观察组,对照组患者采用常规疗法治疗,观察组患者采取rt-PA联合常规疗法进行治疗;比较两组患者治疗前后NIHSS评分、Baethel指数,观察两组患者闭塞血管再通率和并发症发生率。结果:治疗后两组急性脑梗死患者NIHSS评分降低(P<0.05),两组比较差异无统计学意义(P>0.05);治疗后两组急性脑梗死患者Baethel指数均升高(P<0.05),且观察组患者高于对照组(P<0.05),说明观察组患者日常生活能力强于对照组;观察组并发症发生率低于对照组(P<0.05),两组患者闭塞血管再通率比较差异无统计学意义。结论:rt-PA静脉溶栓联合常规疗法可改善急性脑梗死患者日常生活能力,降低并发症发生率。
Objective: To explore the intravenous thrombolysis therapy with recombinant tissue-type plasminogen activator on the patients of acute cerebral infarction. Methods: 28 acute cerebral infarction patients were divided into two groups. The control group was given by conventional therapy,while observation group was given by intravenous thrombolysis therapy with recombinant tissue-type plasminogen activator combined with conventional therapy. NIHSS scores,Baethel index,NSE level,vascular repatency rate and complication rate of patients were compared in the two groups. Results: NIHSS scores of observation group and control group had no statistically significant difference( P > 0. 05).Baethel index in the observation group was significantly higher than in the control group( P < 0. 05).Vascular repatency rate of observation group and control group had no statistically significant difference( P > 0. 05). Complication rate in observation group was significantly lower than in control group( P <0. 05). Conclusion: Intravenous thrombolysis therapy of recombinant tissue-type plasminogen activator with conventional therapy can effectively improve Baethel index and NSE level,and reduce vascular repatency rate. The treatment of acute cerebral infarction can improve the curative effect,and reduce the adverse reaction.

关键词(KeyWords)： 纤溶酶原激活剂;脑梗塞;静脉溶栓;NIHSS评分;Baethel指数
plasminogen activator;cerebral infarction;intravenous thrombolysis;NIHSS score;Baethel index

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81400908)

作者(Author): 吴瑞,李海军,刘胜武,曹钰琨
WU Rui,LI Haijun,LIU Shengwu,CAO Yukun

DOI: 10.19367/j.cnki.1000-2707.2017.06.017

参考文献(References)：

• [1]Yan Z,Yu T,Wang Y,et al.Literature review and case report of intravenous thrombolysis in acute cerebral infarction attributed to cervical arterial dissection[J].J Stroke Cerebrovasc Dis,2015(9):265-269.
• [2]笪正,翟正平,闫福岭.急性脑梗死进展发生的相关危险因素分析[J].中国脑血管病杂志,2014(11):569-575.
• [3]付文亭,李清,邵长娟,等.颅内动脉粥样硬化性狭窄与急性脑梗死进展发生的关系[J].中华老年心脑血管病杂志,2014(10):1061-1064.
• [4]Wang YX,Chen Y,Zhang CH,et al.Study on the effect of urinary kallidinogenase after thrombolytic treatment for acute cerebral infarction[J].Eur Rev Med Pharmacol Sci,2015(6):1009-1012.
• [5]Liu M,Wang HR,Liu JF,et al.Therapeutic effect of recombinant tissue plasminogen activator on acute cerebral infarction at different times[J].World J Emerg Med,2013(3):205-209.
• [6]Lu Y,Wang J,Huang R,et al.Microbubble-mediated sonothrombolysis improves outcome after thrombotic microembolism-induced acute ischemic stroke[J].Stroke,2016(5):1344-1353.
• [7]Gong L,Liu M,Zeng T,et al.Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1[J].Data Brief,2016(6):550-555.
• [8]Suzuki Y,Nagai N,Umemura K.A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia[J].Front Cell Neurosci,2016(10):2-8.
• [9]罗小春,龚文健,李敏辉.不同时间窗重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死的临床分析[J].中华全科医学,2016(5):763-765.
• [10]曲海英,周仁华,徐建红,等.基层医院rt-PA静脉溶栓治疗急性脑梗死临床分析[J].中国实用神经疾病杂志,2015(6):62-64.
• [11]李俐娟,周景芬.不同药物介入治疗脑梗死患者的效果[J].微创医学,2015(1):116-117.
• [12]Lubeck DP,Danese MD,Duryea J,et al.Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke:1998-2011[J].Int J Stroke,2016(2):198-205.
• [13]Berge E,Cohen G,Lindley RI,et al.Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke[J].Stroke,2015(12):3362-3369.
• [14]刘静,吴雅坤,吕宪民,等.急性脑梗死rt-PA溶栓治疗进展[J].河北医科大学学报,2016(3):355-357.
• [15]黄旺,张启确,陈喜炎.Rt-PA和尿激酶溶栓治疗急性脑梗死效果观察[J].现代中西医结合杂志,2014(6):604-605.
• [16]赵秀欣,穆利春,马丽芳.rt-PA静脉溶栓治疗急性脑梗死临床分析[J].中国循证心血管医学杂志,2016(4):486-488.
• [17]莫才周,董自庆,邹细妹.UK与rt-PA在急性脑梗死患者中的应用价值[J].中国实用神经疾病杂志,2015(16):20-22.
• [18]黄敏,李晓波,陈兰兰,等.前后循环急性脑梗死患者重组组织型纤溶酶原激活剂静脉溶栓的临床疗效比较[J].中华老年心脑血管病杂志,2016(4):398-400.
• [19]李辉.重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死的研究[J].现代医药卫生,2015(20):3146-3147.
• [20]党哲,张国鲁,张微微,等.rt-PA联合尿激酶静脉溶栓治疗急性脑梗死的疗效及安全性研究[J].脑与神经疾病杂志,2014(4):287-291.

文章评论(Comment)：